Drug Updates

AUM Biosciences announces closing of $27Million in a “Series A” Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies

AUM Biosciences (AUM) today announced the successful completion of $27 million series A funding round. This will fuel AUM’s vision of developing a world class biotech pipeline focused on drugging what many consider as the undruggable targets, as well as addressing the need to delay and overcome resistance to targeted drugs in oncology. The funding […]